Human γδ T cells from G-CSF-mobilized donors retain strong tumoricidal activity and produce immunomodulatory cytokines after clinical-scale isolation

Journal of Immunotherapy

Volumn 28, Issue 1, 2005, Pages 73-78

  Otto, Mario ^a   Barfield, Raymond C ^a   Iyengar, Rekha ^a   Gatewood, Janet ^a   Müller, Ingo ^b   Holladay, Martha S ^a   Houston, Jim ^a   Leung, Wing ^a   Handgretinger, Rupert ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

CliniMACS; Immunotherapy; Killer cells; Transplantation; T cells

Indexed keywords

CD11B ANTIGEN; CD18 ANTIGEN; CD28 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; LYMPHOCYTE ANTIGEN RECEPTOR;

ADOPTIVE IMMUNOTHERAPY; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOANALYSIS; CANCER CELL CULTURE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; ERYTHROLEUKEMIA CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOMAGNETIC SEPARATION; IMMUNOMODULATION; IN VITRO STUDY; LEUKAPHERESIS; NEUROBLASTOMA CELL; PHENOTYPE; PRIORITY JOURNAL; PURIFICATION; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY; BLOOD DONOR; CYTOTOXICITY; CYTOTOXICITY TEST; DRUG EFFECT; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; METHODOLOGY; MONONUCLEAR CELL; STEM CELL MOBILIZATION; TUMOR CELL LINE;

BLOOD DONORS; CELL LINE, TUMOR; CYTOKINES; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; IMMUNOMAGNETIC SEPARATION; IMMUNOPHENOTYPING; IMMUNOTHERAPY, ADOPTIVE; LEUKAPHERESIS; LEUKOCYTES, MONONUCLEAR; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES, CYTOTOXIC;

EID: 11344259248     PISSN: 15249557     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002371-200501000-00009     Document Type: Article

References (34)

1. Raulet DH. The structure, function, and molecular genetics of the gamma/delta T cell receptor. Annu Rev Immunol. 1989;7:175-207.
2. Carding SR, Egan PJ. The importance of gamma delta T cells in the resolution of pathogen-induced inflammatory immune responses. Immunol Rev. 2000;173:98-108.
3. Born W, Cady C, Jones-Carson J, et al. Immunoregulatory functions of gamma delta T cells. Adv Immunol. 1999;71:77-144.
4. Lopez RD. Human gamma delta-T cells in adoptive immunotherapy of malignant and infectious diseases. Immunol Res. 2002;26:207-221.
5. Lamb LS Jr, Musk P, Ye Z, et al. Human gammadelta(+) T lymphocytes have in vitro graft vs. leukemia activity in the absence of an allogeneic response. Bone Marrow Transplant. 2001;27:601-606.
6. Lowdell MW, Lamb L, Hoyle C, et al. Non-MHC-restricted cytotoxic cells: their roles in the control and treatment of leukaemias. Br J Haematol. 2001;114:11-24.
7. Thomas ML, Badwe RA, Deshpande RK, et al. Role of adhesion molecules in recruitment of Vdelta1 T cells from the peripheral blood to the tumor tissue of esophageal cancer patients. Cancer Immunol Immunother. 2001;50:218-225.
8. Boismenu R, Havran WL. Gamma delta T cells in host defense and epithelial cell biology. Clin Immunol Immunopathol. 1998;86:121-133.
9. Rust C, Orsini D, Kooy Y, et al. Reactivity of human gamma-delta T cells to staphylococcal enterotoxins: a restricted reaction pattern mediated by 2 distinct recognition pathways. Scand J Immunol. 1993;38:89-94.
10. Shen Y, Zhou D, Qiu L, et al. Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections. Science. 2002;295:2255-2258.
11. Dechanet J, Merville P, Pitard V, et al. Human gamma delta T cells and viruses. Microbes Infect. 1999;1:213-217.
12. Hayday A, Tigelaar R. Immunoregulation in the tissues by gamma delta T cells. Nat Rev Immunol. 2003;3:233-242.
13. Ferrarini M, Ferrero E, Dagna L, et al. Human gamma delta T cells: a nonredundant system in the immune-surveillance against cancer. Trends Immunol. 2002;23:14-18.
14. Schilbach K, Geiselhart A, Handgretinger R. Induction of proliferation and augmented cytotoxicity of gamma delta T lymphocytes by bisphosphonate clodronate. Blood. 2001;97:2917-2918.
15. Thompson J, Guichard SM, Cheshire PJ, et al. Development, characterization and therapy of a disseminated model of childhood neuroblastoma in SCID mice. Cancer Chemother Pharmacol. 2001;47:211-221.
16. Handgretinger R, Lang P, Ihm K, et al. Isolation and transplantation of highly purified autologous peripheral CD34(+) progenitor cells: purging efficacy, hematopoietic reconstitution and long-term outcome in children with high-risk neuroblastoma. Bone Marrow Transplant. 2002;29:731-736.
17. Despres D, Flohr T, Uppenkamp M, et al. CD34(+) cell enrichment for autologous peripheral blood stem cell transplantation by use of the CliniMACS device. J Hematother Stem Cell Res. 2000;9:557-564.
18. Brenner MB, McLean J, Dialynas DP, et al. Identification of a putative second T-cell receptor. Nature. 1986;322:145-149.
19. Bank I, DePinho RA, Brenner MB, et al. A functional T3 molecule associated with a novel heterodimer on the surface of immature human thymocytes. Nature. 1986;322:179-181.
20. Aljurf M, Ezzat A, Musa O. Emerging role of gamma delta T-cells in health and disease. Blood Rev. 2002;16:203-206.
21. Hayday AC. Gamma delta cells: a right time and a right place for a conserved third way of protection. Annu Rev Immunol. 2000;18:975-1026.
22. Nagai M, Azuma E, Qi J, et al. Suppression of alloreactivity with gamma delta T-cells: relevance to increased gamma delta T-cells following bone marrow transplantation. Biomed Pharmacother. 1998;52:137-142.
23. Kawanishi Y, Passweg J, Drobyski WR, et al. Effect of T cell subset dose on outcome of T cell-depleted bone marrow transplantation. Bone Marrow Transplant. 1997;19:1069-1077.
24. Drobyski WR, Majewski D, Hanson G. Graft-facilitating doses of ex vivo activated gamma delta T cells do not cause lethal murine graft-vs.-host disease. Biol Blood Marrow Transplant. 1999;5:222-230.
25. Gordon PR, Leimig T, Babarin-Dorner A, et al. Large-scale isolation of CD133+ progenitor cells from G-CSF mobilized peripheral blood stem cells. Bone Marrow Transplant. 2003;31:17-22.
26. Carding SR, Egan PJ. Gamma delta T cells: functional plasticity and heterogeneity. Nat Rev Immunol. 2002;2:336-345.
27. Kabelitz D, Glatzel A, Wesch D. Antigen recognition by human gamma delta T lymphocytes. Int Arch Allergy Immunol. 2000;122:1-7.
28. Poles MA, Barsoum S, Yu W, et al. Human immunodeficiency virus type 1 induces persistent changes in mucosal and blood gamma delta T cells despite suppressive therapy. J Virol. 2003;77:10456-10467.
29. Narazaki H, Watari E, Shimizu M, et al. Perforin-dependent killing of tumor cells by Vgamma1Vdelta1-bearing T-cells. Immunol Lett. 2003; 86:113-119.
30. Meehan KR, Wu A, Hassan R, et al. Ex vivo cytokine activation of peripheral blood stem cells: a potential role for adoptive cellular immunotherapy. J Hematother Stem Cell Res. 2001;10:283-290.
31. Huang Y, Wange RL. T cell receptor signaling: beyond complex complexes. J Biol Chem. 2004;279:28827-28830.
32. Inose K, Ono K, Tsutida A, et al. Active inhibitory effect of nafamostat mesylate against the elevation of plasma myeloperoxidase during hemodialysis. Nephron. 1997;75:420-425.
33. Scholz M, Simon A, Matheis G, et al. Leukocyte filtration fails to limit functional neutrophil activity during cardiac surgery. Inflamm Res. 2002; 51:363-368.
34. Todeschini M, Macconi D, Fernandez NG, et al. Effect of acetate-free biofiltration and bicarbonate hemodialysis on neutrophil activation. Am J Kidney Dis. 2002;40:783-793.